Science · Innovation · Impact

Drug Discovery &
Development Expert

Translating cutting-edge science into therapeutic breakthroughs. Strategic consulting across immunology, oncology, and rare diseases for biotech and pharmaceutical companies.

20+ Years of Experience
3 Therapeutic Areas
7+ Drug Modalities
Harvard · IU Postdoctoral Training
Dr. Andrej Jedinak, PhD

Meet Dr. Andrej Jedinak

PhD · Drug Discovery Consultant · Scientific Advisor

Dr. Andrej Jedinak is a seasoned drug discovery and development expert with over two decades of experience spanning academia and the biopharmaceutical industry. Trained at Harvard Medical School and Indiana University, he brings a rare combination of deep mechanistic biology and translational expertise.

His work spans immunology, oncology, and rare metabolic diseases, with hands-on experience across diverse therapeutic modalities — from small molecules and biologics to RNAi and gene therapy approaches.

Immunology Oncology Rare Diseases RNAi / Gene Therapy Translational Science
Full Profile →

Therapeutic Expertise

Deep scientific knowledge and hands-on research experience across three core therapeutic domains.

🧬

Immunology & Autoimmune

Mechanistic expertise in immune modulation, autoimmune pathways, and inflammatory disease biology for therapeutic target identification and validation.

Explore Immunology →
🔬

Oncology & Immuno-Oncology

Comprehensive cancer biology expertise covering tumor microenvironment, checkpoint biology, and novel immuno-oncology targets across multiple tumor types.

Explore Oncology →
⚗️

Rare & Metabolic Diseases

Strategic expertise in rare disease drug development including orphan drug designation, biomarker strategy, and patient-centric development approaches.

Explore Rare Diseases →

Services & Capabilities

End-to-end drug discovery support from target identification through IND-enabling studies.

🎯

Drug Discovery

Full-spectrum drug discovery support from target identification and validation through hit discovery, lead optimization, and candidate selection strategies.

Learn more →
🧪

In Vitro Pharmacology

Comprehensive in vitro pharmacology study design, execution oversight, and data interpretation for mechanism of action and potency characterization.

Learn more →
🐭

In Vivo Pharmacology

Strategic design and oversight of in vivo efficacy and safety studies across multiple disease models with translational biomarker integration.

Learn more →
🔭

Translational Science

Bridging preclinical findings to clinical applications through biomarker identification, patient stratification strategies, and translational frameworks.

Learn more →
View All Services

End-to-End Drug Discovery Support

Expert guidance at every stage of the drug discovery and development continuum.

1
Target Identification
2
Target Validation
3
Hit Discovery
4
Lead Optimization
5
Preclinical Development
6
IND & Clinical

Ready to Advance Your Pipeline?

Let's discuss how deep scientific expertise and strategic consulting can accelerate your drug discovery program.